Becton, Dickinson Announced Global Commercial Release Of New Cell Sorters To Enable More Researchers In Broader Range Of Fields, Including Cell Biology, Cancer Research And Immunology In Traditional Flow Cytometry Experiments
Portfolio Pulse from Benzinga Newsdesk
Becton, Dickinson (BDX) announced the global commercial release of new BD FACSDiscover S8 Cell Sorters, featuring BD CellView Image Technology and BD SpectralFX Technology. These technologies, which were highlighted on the cover of Science journal in 2022, aim to enhance research in fields such as cell biology, cancer research, and immunology by providing more access, options, and flexibility for real-time imaging and spectral flow cytometry experiments. The release includes three- and four-laser versions, complementing the previously launched five-laser instrument.
April 05, 2024 | 10:49 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Becton, Dickinson's release of the BD FACSDiscover S8 Cell Sorters with advanced imaging and spectral technologies represents a significant enhancement in the tools available for research in cell biology, cancer research, and immunology.
The introduction of the BD FACSDiscover S8 Cell Sorters with BD CellView Image Technology and BD SpectralFX Technology by Becton, Dickinson is likely to be positively received by the scientific community, enhancing the company's reputation in the field. The technologies' previous profiling on the cover of Science journal in 2022 adds credibility and visibility, potentially leading to increased demand for these instruments. This could have a positive short-term impact on BDX's stock price as the market reacts to the potential for increased sales and market penetration in research fields.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90